BioHarvest - CEO, Ilan Sobel
CEO, Ilan Sobel
Source: BioHarvest
  • BioHarvest Sciences (BHSC) is exploring opportunities to acquire an existing licensed facility or a Licensed Producer
  • BioHarvest has moved its production of full-spectrum cannabis biomass to industrial scale bioreactors
  • BioHarvest Sciences is a biotechnology company
  • Shares in BioHarvest Sciences Inc. (BHSC) opened trading at C$0.35 per share

BioHarvest Sciences (BHSC) is exploring opportunities to acquire an existing licensed facility or a Licensed Producer in Canada.

The company has also moved its production of full-spectrum cannabis biomass to industrial-scale bioreactors, a final step in ensuring adequate production levels for commercialization. This full-spectrum, pesticide-free, non-genetically modified biomass is based on the company’s proprietary BioFarming technology that produces Cannabis without growing the plant itself.

Late last year, the company announced that it was the first to produce a significant amount of full-spectrum, non-GMO cannabis biomass without growing the cannabis plant itself. BioHarvest has now moved towards the final stage of the development program by growing the Trichome cells in industrial-scale bioreactors.

The Trichome cells contain cannabinoids such as CBD, THC, as well as other compounds that grow naturally in the cannabis plant. This stage successfully tested the resilience of BioHarvest’s proprietary “amalgamated Trichome cells” against the shear forces generated by the large bioreactor’s liquid media motion. 

Ilan Sobel, CEO of BioHarvest remarked on the company’s technology.

“Our BioFarming technology not only enables the production of full-spectrum cannabis without growing the plant but also creates unique new patentable and consistent compositions that will have corresponding human utility value.”

He continued, “I am excited about the opportunity to bring such unique cannabis solutions to the Canadian market by building a local production facility in Canada. To that end, we have started the engagement for finding an adequate facility and/or acquiring an existing LP who has the appropriate licenses.”

BioHarvest Sciences is a biotechnology company that has developed a proprietary and patent-protected bio-farming technology.

Shares in BioHarvest Sciences Inc. (BHSC) opened trading at C$0.35 per share.

More From The Market Online
MDA - The Canadarm in action.

MDA’s $250M contract extension supports ISS robotics operations

MDA Space (TSX:MDA) receives a C$250 million contract extension to support robotics operations on the International Space Station.